(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis
Trial details
- Registry ID
- NCT05186753
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CGT9486; PLX9486
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic MastocytosisNCT05186753 | COGT | Phase 2 | Active not recruiting | 2025-05-22Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |